CBD who’s who: Leading Edge Pharms


Leading Edge Pharms is a biotechnology company focused on the research, development and commercialization of novel cannabinoid therapies and innovative delivery platforms. The company’s Cannavera product line features its first commercial product, Silvidiol, a proprietary compound formulated with THC-free broad spectrum organic CO2 hemp extract and Emerald Aloe Vera. Cannavera topical oil, crème, ointment and liquid products are natural, nonsystemic, free of THC and marketed as a step-wise approach to pain management therapy in the opioid-alternative category.

What differentiates Henderson, Nev.-based Leading Edge Pharms from other companies is the years of research, according to CEO David Chadwick. “If you’re going to reference pain relief and make specific medical type claims, you have to have research to back it up,” he said. “You have a company like ours that spends four years of formulating and doing studies, and then you have folks who get into the business almost overnight.”


Leave a Reply

No comments found



What area is your company focused most on in 2019?
  • Add your answer